Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01464255 · ClinicalTrials.gov registry record · NA
Comparative Study of Two Marketed 1-day Soft Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT01464255 is a NA study that has completed, run by CooperVision. The registered enrollment target is 71 participants.
The verdict
NCT01464255, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
This study is designed to evaluate ocufilcon D lens compared to ocufilcon B lens in a 1-week crossover, daily wear regimen.
Interventions
- DEVICE ocufilcon D
- DEVICE ocufilcon B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01464255
The ClinicalTrials.gov registry entry for NCT01464255 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ocufilcon D is the first listed.
NCT01464255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01464255 about?
NCT01464255 is a clinical study titled "Comparative Study of Two Marketed 1-day Soft Contact Lenses". This study is designed to evaluate ocufilcon D lens compared to ocufilcon B lens in a 1-week crossover, daily wear regimen.
What is the current status of trial NCT01464255?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2011-08. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01464255?
The interventions under investigation include: ocufilcon D (DEVICE), ocufilcon B (DEVICE).
Who is sponsoring clinical trial NCT01464255?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.